Navigation Links
Efficient RNAi-mediated gene silencing in neuronal cells using QIAGEN ,,, siRNA and TransMessenger Transfection Reagent*

Anna M. Krichevsky and Kenneth S. Kosik
Center for Neurologic Diseases, Brigham and Womens Hospital, Harvard Medical School, Boston, MA, USA Genetic manipulations using neuronal cells are notoriously difficult. Therefore, efficient delivery of short interfering RNA (siRNA) to primary neuronal cultures is of critical importance for RNA interference (RNAi)-mediated gene suppression. Here we describe successful targeted suppression of gene expression using TransMessenger Transfection Reagent and synthetic siRNA directed against microtubule-associated protein 2 (MAP2). RNAi has become a powerful tool used to knock down the expression of genes in cultured mammalian cells. However, neuronal cells, which are difficult to manipulate, have seemed to be more resistant to RNAi than other cell types. The reasons for this are unclear. Differences in siRNA uptake across the neuronal cell membrane or the RNAi pathway itself are possible causes. In this study, synthetic siRNA was used to successfully suppress expression of MAP2.

Materials and methods Two QIAGEN siRNAs targeted against MAP2 mRNA were designed with a 5' phosphate, 3' hydroxyl, and two-base overhangs on each strand (see Table "siRNA sequences used to target endogenous MAP2 mRNA in neuronal cells"). Transfections of siRNA for gene targeting were performed using TransMessenger Transfection Reagent as described in the TransMessenger Transfection Reagent Handbook. siRNA (1 g per well) was condensed with Enhancer R and complexed with 4 l TransMessenger Reagent. The transfection complexes were diluted in 900 l of neurobasal medium and added directly to the cells. Medium containing transfection complexes was removed and replaced with neurobasal medium after 2 hours incubation. Cells were stained and analyzed after transfection. Double immunofluorescence labeling and image analysis was performed as described previously (1). siRNA sequences used to target endogenous MAP2 mRNA in neuronal cells Results and discussion The effect of siRNA-mediated RNAi on neuronal cells was tested using siRNA targeted against MAP2 endogenous mRNA. During the course of this study, it was noted that siRNA was more readily introduced into cells than plasmid DNA was. Cells were targeted with siRNA 58 days after plating. Double immunofluorescence labeling of MAP2 and the unrelated protein actin was performed 48 to 68 hours after transfection. The expression of MAP2 was specifically reduced in 7080% of cells, whereas the expression of an unrelated protein (f-actin) was unaffected (see Figure "Efficient Transfection of Primary Neuronal Cells Using QIAGEN siRNA and TransMessenger Reagent"). Transfection of either siRNA targeting MAP2 (siRNA1 or siRNA2) resulted in an identical level of inhibition of MAP2 expression. Efficient Transfection of Primary Neuronal Cells Using QIAGEN siRNA and TransMessenger Reagent Primary neuronal cells from rats were transfected with a control nonspecific siRNA or an siRNA directed against MAP2 using TransMessenger Transfection Reagent. Cells were stained 4868 hours after transfection using mouse monoclonal anti-MAP2 antibodies and Alexa Fluor 488-conjugated goat anti-mouse secondary antibody (MAP2) and Alexa Fluor 594-conjugated phalloidin, which binds to f-actin and serves here as an expression control. Suppression of MAP2 Leads to Defective Neuronal Development Primary neuronal cells from rats were transfected with an siRNA directed against MAP2 using TransMessenger Transfection Reagent. Primary cultures were targeted with siRNA 3 hours after plating and analyzed over 2840 hours. Cells were stained using mouse monoclonal anti-MAP2 antibodies and Alexa Fluor 488-conjugated goat anti-mouse secondary antibody (MAP2) and Alexa Fluor 594-conjugated phalloidin. The cell with silenced MAP2 expression (arrowed) exhibits severely defective filopodial elaboration.

MAP2 has been shown to be required to overcome early transitions of neuritic development and to begin elongation of neuritic processes (2, 3). Phenotypic effects of MAP2 suppression can be observed early on after plating so primary neuronal cultures were targeted with siRNA 3 hours after plating and the effect was analyzed over 28 to 40 hours. Within the shorter time frame, fewer neurons suppressed MAP2 expression, however the degree of MAP2 suppression correlated with a recognized defect in filopodia elaboration (see Figure "Suppression of MAP2 Leads to Defective Neuronal Development").

Conclusions
  • Our results show that TransMessenger Transfection Reagent can be used to successfully transfect primary neuronal cells with synthetic QIAGEN siRNA and effectively suppress target gene expression. Transfection of synthetic siRNA using the non-liposomal TransMessenger Reagent is an attractive alternative to transfection using other lipid-based reagents, which are often toxic to neuronal cells.

  • As primary neuronal cells are difficult to transfect with DNA, the high transfection efficiency acheived using siRNA and TransMessenger Transfection Reagent (7080%) suggests that neuronal cells, at least, are better suited to RNAi experiments using synthetic siRNA than RNAi experiments that require plasmid DNA to be transfected.

  • The application of RNAi techniques to neurons, a setting where genetic manipulations have traditionally proven difficult, will be a valuable tool in studies on neuronal gene-regulation and function.
References
  1. Krichevksy, A., and Kosik, K. (2002) RNAi functions in cultured mammalian neurons.

  2. Proc. Natl. Acad. Sci. USA 99, 11926. Gonzalez-Billault, C. (2002) Participation of structural microtubuleassociated proteins (MAPs) in the development of neuronal polarity. J. Neurosci. Res. 67, 713.

  3. Caceres, A., Muatinoem J., and Kosik, K. (1992) Suppression of MAP2 in cultured cerebellar macroneurons inhibits minor neurite formation. Neuron. 9, 607.
  4. Transfection Reagent Selector Kit Handbook
* Data excerpted from Krichevsky, A.M. and Kosik, K.S. (2002) RNAi functions in cultured mammalian neurons.


'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Efficiently Insert Unique Restriction Sites into Plasmid Vectors
2. Efficient Cleavage of Fusion Proteins to Yield Native Amino Termini
3. Mammalian Expression Vector for Efficient Cloning of PCR Fragments
4. Efficient Transfection of Neurospora Crassa
5. Efficient Transfection of Neurospora Crassa
6. Efficient Recovery of Ultrapure Plasmid DNA
7. Efficient and Reliable PCR Setup Using Eppendorf MasterMix
8. Efficient DNA transfection of primary CNS neurons using TransMessenger Transfection Reagent
9. Cloning Based on Efficient Three-Fragment Assembly DNA Ligation
10. Efficient and Reliable Linear Amplification of cRNA
11. Efficient Delivery of siRNAs to Human Primary Cells: Electroporation vs. Chemical Transfection
Post Your Comments:
(Date:1/23/2015)... Portal Solutions , a technology consulting firm that ... 365 and SharePoint platforms , today announces its inclusion in ... of the region’s fastest-growing mid-sized companies based on a combined ... be recognized a second year in a row by SmartCEO ...
(Date:1/22/2015)...  Transwestern | RBJ today announces the firm brokered a long-term ... a leading biopharmaceutical company, at Two Ledgemont Center in ... Richards , president, and Brian Cohen , senior vice ... building at 95 Hayden Ave. Photo - ...
(Date:1/22/2015)... San Diego, California (PRWEB) January 22, 2015 ... R Promotional Offer to their comprehensive portfolio of ... Offer allows customers to purchase a Centrifuge 5424/5424 R ... Pipette Bundle of either Eppendorf Research plus or Eppendorf ...
(Date:1/22/2015)... Diagenode, Inc., a leading global provider ... complete solutions for epigenetics research, recently launched a ... need for manual processing. The new ChIPettor System ... histones or transcription factors and a semi-automated pipette ...
Breaking Biology Technology:Washington SmartCEO Announces Portal Solutions as 2015 Future 50 Award Winner Second Year in a Row 2Washington SmartCEO Announces Portal Solutions as 2015 Future 50 Award Winner Second Year in a Row 3Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2
... April 7 Transgenomic, Inc. (OTC Bulletin Board: TBIO), ... completed a licensing option with the Dana-Farber Cancer Institute, ... Cold-PCR. This variation of the standard PCR technology ... was invented at Dana-Farber by Dr. Mike Makrigiorgos who ...
... WellGen, Inc. today announced that Dr. Roderick (Roddy) ... Executive Officer. Dr. Carter, 45, takes over ... Chief Executive Officer. Mr. Bertoldi will continue in ... Financial Officer of Amphion Innovations plc (LSE: AMP), a ...
... Inc. today announced that it has secured $38 million ... formation in 2004, the company has raised $92 million ... financing round, which consists of two tranches, was led ... pro rata participation of existing investors Apax Partners, Clarus ...
Cached Biology Technology:Transgenomic Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations 2Transgenomic Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations 3Transgenomic Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations 4Dr. Roddy Carter Named President and Chief Executive Officer of WellGen, Inc. 2Dr. Roddy Carter Named President and Chief Executive Officer of WellGen, Inc. 3Aerovance Secures $38 Million in Equity Financing 2Aerovance Secures $38 Million in Equity Financing 3
(Date:1/22/2015)... Jan. 13, 2015  Today, FreeWavz ( www.FreeWavz.com ), ... crowdfunding campaign on Fundable, https://www.fundable.com/freewavz . FreeWavz ... production capacity to meet customer demand. ... http://photos.prnewswire.com/prnh/20150113/168790 Invented by ...
(Date:1/22/2015)... 15, 2015  BellBrook Labs, a leader in high ... launch of a TR-FRET (time resolved Forster resonance ... Assay, a high throughput screening assay for glycosyltransferases ... allow for sensitive detection of hundreds of human ...
(Date:1/22/2015)... Inc. (NASDAQ: NXTD and NXTDW) a biometric authentication company ... of the Wocket™ smart wallet at CES 2015 in Las ... one of the "11 Hot Products at CES" in a review published ... Far" by Newseveryday.com and "The top 10 gadgets from CES 2015" by ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
... working in College of Life Science, Zhejiang University, has ... CpG island has a parental differentially methylated region (DMR). ... imprinting exists in lower vertebrates and genomic imprinting should ... mammals. The study is reported in volume 54 (Issue ...
... A team of University of Oregon biologists, using fruit ... specific cells, opening a new window on how gene ... While DNA (deoxyribonucleic acid) provides an identical genetic blueprint ... that turn protein molecules on and off in different ...
... is the latest American Chemical Society (ACS) Weekly PressPac ... from ACS, 34 peer-reviewed journals and Chemical & Engineering ... Society as the source for this information. ... melamine-adulterated food , Journal of Agricultural and Food ...
Cached Biology News:The evolutionary foundation of genomic imprinting in lower vertebrates 2New tool isolates RNA within specific cells 2American Chemical Society's Weekly PressPac -- May 13, 2009 2American Chemical Society's Weekly PressPac -- May 13, 2009 3American Chemical Society's Weekly PressPac -- May 13, 2009 4American Chemical Society's Weekly PressPac -- May 13, 2009 5American Chemical Society's Weekly PressPac -- May 13, 2009 6American Chemical Society's Weekly PressPac -- May 13, 2009 7American Chemical Society's Weekly PressPac -- May 13, 2009 8American Chemical Society's Weekly PressPac -- May 13, 2009 9American Chemical Society's Weekly PressPac -- May 13, 2009 10
... for monitoring acetylcholinesterase (AChE) activity. This is ... 5 min), non-radioactive and easy to use ... natural substrate, acetylcholine. A series of coupled ... AChE into a change in luminescence. Inhibitors ...
... Pulsed Dynamic Focusing MALDI (PDF-MALDI) source provides ... that do not need online separation. Paired ... LC/MS and Agilents powerful Spectrum Mill software, ... analysis of 2D gel-spot digests. It provides ...
Rabbit polyclonal to Vitronectin ( Abpromise for all tested applications). Antigen: Full length Vitronectin protein (Mouse). Entrez Gene ID: 7448 Swiss Protein ID: P04004...
... The Vibratome Roto-Shake Genie is ... platform. It performs five different ... rolling/rocking and rotating/rolling, as well as ... The precision-engineered moving portion of ...
Biology Products: